Latest in Research & Development

Bringing CAR-T therapy within reach: how decentralised manufacturing will improve patient access

By offering a lifeline to patients with otherwise untreatable conditions, CAR-T cell therapy has transformed cancer treatment. Yet, despite the breakthrough potential of these patient-specific therapies, access remains severely limited

Find out more
You need to be a subscriber to read this article.
Click here to find out more.

Omron and Cognizant to offer IT/OT integration services to pharmaceutical manufacturers

Together, Omron and Cognizant will help manufacturers to integrate IT-OT into their operations and maintenance processes
See more

Capricorn Scientific and florabio join forces to supply animal-free vaccine solutions

Strategic partnership will accelerate innovation from lab to GMP scale with high-yield solutions for scalable production

Pfizer discontinues development of GLP-1 receptor agonist, danuglipron

The oral GLP-1 receptor agonist was discontinued due to reports of potential drug-induced liver toxicity in one patient during phase III trials

Novartis to invest $23bn into US manufacturing and R&D capacity

The US investment will involve the construction of seven new manufacturing facilities, as well as a biomedical research innovation hub in San Diego

Lonza and Ethris team up to develop mRNA vaccines for respiratory diseases

The two hope to produce a temperature-stable mRNA vaccine for influenza, which may promote mucosal immunity through its nasal delivery system
You need to be a subscriber to read this article.
Click here to find out more.

Streamlining TFF with Vivaflow SU from Sartorius and a Watson‑Marlow peristaltic pump

Critical to the performance of Vivaflow SU, a tangential flow filtration (TFF) cassette recently released by Sartorius, is a laboratory pump capable of delivering a consistent flow rate during ultrafiltration and diafiltration

BioDuro opens Chinese HPAPI synthesis laboratory

The Shanghai laboratory operates within OEB-5, producing highly potent compounds for use in early-stage drug conjugate development studies

Opening new doors to precision medicine with single-stranded DNA (ssDNA): part II

In the second part of this article, the benefits of ssDNA in terms of efficient cellular uptake and stability, the application of self-folding nanocarriers for gene delivery and mechanisms of action are discussed, along with a forward-thinking review of future perspectives and challenges

Preparing for the future of contained oncology drug production

Advancements in oncology drug production, containment technologies, and automation have manifestly improved the safety, efficiency, and precision aspects of manufacturing highly potent cancer treatments

Latest posts in Research & Development

Opening new doors to precision medicine with single-stranded DNA (ssDNA): part I

In this two-part article, the science behind ssDNA manufacturing is explored, along with the innovations that are enhancing the therapeutic benefits of ssDNA-derived constructs. A comparative analysis of traditional double-stranded DNA (dsDNA) and other nucleic acid-based methods is also included

Johnson & Johnson to invest $55bn into US manufacturing, R&D and tech

The company will build three new advanced pharmaceutical manufacturing facilities on top of its biologics manufacturing site in Wilson, North Carolina, which is currently under construction

AstraZeneca puts $2.5bn into Chinese R&D and manufacturing capabilities

The pharmaceutical giant will establish its sixth strategic R&D centre in China, as well as novel research and manufacturing agreements in the region

Servier to develop and commercialise targeted solid tumour therapy, BDTX-4933

Through a worldwide licensing agreement, Servier will commercialise Black Diamond Therapeutics' targeted small molecule therapeutic for patinets with RAF/RAS-mutant solid tumours
You need to be a subscriber to read this article.
Click here to find out more.

PROTACs: current landscape and their significance in drug discovery

PROteolysis TArgeting Chimeras (PROTACs) represent a revolutionary approach to drug discovery that leverages their chemically induced proximity to degrade disease-causing proteins using the cellular ubiquitin-proteasome system

Sofinnova Partners closes €165m Biovelocita II biotech programme, launches BioClec

The Biovelocita II programme received funding from key pharmaceutical players such as Pfizer, Bristol Myers Squibb and Amgen, and will facilitate the launch of early-stage Alzheimer's biotech, BioClec

Shilpa Biologicals to co-develop and commercialise mAbTree Biologics' monoclonal antibody

The monoclonal antibody (mAb) is designed to treat a range of cancers, including haematological malignancies, lung and head & neck carcinomas

Taiho Pharmaceutical to acquire ADC biotech, Araris

The acquisition will enhance Taiho Pharmaceutical's next-generation cancer pipeline, costing the company up to $1.14bn

Boehringer Ingelheim and Salipro Biotech partner to develop novel therapeutics

Together, the companies aim to develop therapeutics targeting GPRCs, ion channels and transporters for mental health and metabolic diseases

Roche expands GLP-1 cardiometabolic portfolio with Zealand Pharma collaboration

Together, the companies will co-develop and commercialise a combination of Zealand Pharma's amylin analog, petrelintide, and Roche's lead incretin GLP-1 receptor agonist, CT-388

CordenPharma to build new peptide manufacturing facility in Muttenz, Switzerland

The >€500m investment is part of the CDMO's €1bn initiative to boost its global peptide development and manufacturing capacity

FairJourney Biologics acquires Charles River's US antibody discovery site

The antibody discovery and engineering site in South San Francisco, US will expand FairJourney's reach in the key North American market, while positioning the company in one of the world's largest biotech clusters

Sponsor content

Beyond performance: GF’s SYGEF turns 50

PVDF piping systems continue to provide trusted solutions for demanding industries

Titan Enterprises powers forward with green initiatives

Strategic investments in solar, supply chain and recycling drive sustainability

Phastar secures finalist spot at 2025 Citeline Awards

Specialist biometrics and data science CRO named in accolade shortlist for ‘CRO Partnership of the Year’ award

Chemspec Europe 2025 to showcase innovation in fine and speciality chemicals

Leading global trade fair returns to Cologne with a focus on sustainability, regulation, and R&D

Expansion of oil-free parallel stirring platform enhances reaction screening

Asynt improves DrySyn Vortex system to support standard glassware and simultaneous multi-flask stirring

How pre-assembled packaging helps pharmaceutical manufacturers

Faller Packaging’s PrePackaging Service enables faster market entry

Cytiva broadens Xcellerex X-platform to include 500L and 2 000L bioreactors

New single-use bioreactors improve scalability and efficiency for advanced therapeutics

Oligonucleotides cleavage breakthrough with Vapourtec system

Scientists at Novo Nordisk in Denmark have applied flow chemistry to enhance the cleavage of oligonucleotides.

Biotech Fluidics introduces HPLC Pump Validation Kit for precise flow monitoring

New flowmeter kit offers real-time validation and performance tracking

Kindeva: beyond the shop floor

As a leading global CDMO, we are committed to staying ahead of the curve and providing you with the innovative solutions you need to succeed now and in the future

European laboratories face severe budget cuts and staff shortages

Survey reveals 64% of laboratories are already implementing cost-saving measures, jeopardizing future research potential

Lucideon’s new in vitro cell lab accelerates next-generation capability

Lucideon is advancing its global position in pharmaceutical and biotech product development with investment in a new in vitro cell biology lab. The pioneering facility...

Featured companies

At Biotech Fluidics, our aim is to help you make your analytical work more effective and reliable. CARBOGEN AMCIS is a global Contract Development and Manufacturing Organization (CDMO) providing drug development and commercialization services to the pharmaceutical and... At Lonza, we enable a healthier world by supporting our healthcare customers on the path to commercialization. Our community of around 17,500 skilled employees work across a... PCI Pharma Services: Your bridge between life-changing therapies and patients.
See more